Package 50090-2101-3

{"route": ["ORAL"], "spl_id": "40bb864c-a964-4b3d-8613-977890d4326a", "openfda": {"unii": ["G447S0T1VC"], "rxcui": ["313564", "313565"], "spl_set_id": ["cb929bed-0e7d-4543-9020-edfda93d78fc"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "15 TABLET in 1 BOTTLE (50090-2101-0)", "package_ndc": "50090-2101-0", "marketing_start_date": "20151013"}, {"sample": false, "description": "21 TABLET in 1 BOTTLE (50090-2101-1)", "package_ndc": "50090-2101-1", "marketing_start_date": "20151013"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (50090-2101-2)", "package_ndc": "50090-2101-2", "marketing_start_date": "20151013"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (50090-2101-3)", "package_ndc": "50090-2101-3", "marketing_start_date": "20151013"}], "brand_name": "Valacyclovir hydrochloride", "product_id": "50090-2101_40bb864c-a964-4b3d-8613-977890d4326a", "dosage_form": "TABLET", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "50090-2101", "generic_name": "Valacyclovir hydrochloride", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Valacyclovir hydrochloride", "active_ingredients": [{"name": "VALACYCLOVIR HYDROCHLORIDE", "strength": "1000 mg/1"}], "application_number": "ANDA077135", "marketing_category": "ANDA", "marketing_start_date": "20100524", "listing_expiration_date": "20261231"}